<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H003081AFC08C487CB8D065676E793C18" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 6948 IH: To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to promulgate rules to update certain regulations relating to human cells, tissues, and cellular and tissue-based products, and for other purposes.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-03-07</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 6948</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220307">March 7, 2022</action-date><action-desc><sponsor name-id="C001120">Mr. Crenshaw</sponsor> (for himself and <cosponsor name-id="B001248">Mr. Burgess</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to promulgate rules to update certain regulations relating to human cells, tissues, and cellular and tissue-based products, and for other purposes.</official-title></form><legis-body id="H4863ED6B64E54871A0AECC014BF6EC83" style="OLC"><section id="H1E89D8E9B33E4F49A47579D91A68DC64" section-type="section-one"><enum>1.</enum><header>Updating certain regulations relating to human cells, tissues, and cellular and tissue-based products</header><subsection id="H3C59F172B2DF41DF8211DEBE741B6A35"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall update the regulations in part 1271 of title 21, Code of Federal Regulations (as in effect on the date of the enactment of this Act), including such revisions as may be necessary to update the definition of the term <term>minimal manipulation</term> specified in section 1271.3 of title 21, Code of Federal Regulations (as in effect on such date of enactment).</text></subsection><subsection id="HC6E29FE2A80940ADAD0005907B3B1063"><enum>(b)</enum><header>Timeline</header><text>The Secretary shallâ€”</text><paragraph id="HE1BA1130ECF942B7915BAF25CF43E66D"><enum>(1)</enum><text>issue proposed regulations to carry out the updates required under subsection (a) not later than 1 year after the date of the enactment of this Act; and</text></paragraph><paragraph id="H078918E6D62947F9B16F2760540F3C74"><enum>(2)</enum><text>finalize such proposed regulations not later than 1 year after the date on which such proposed regulations are issued. </text></paragraph></subsection></section></legis-body></bill> 

